|Mr. Stavros George Vizirgianakis||CEO & Director||554.15k||N/A||1970|
|Mr. Joseph P. Dwyer||CFO, Treasurer & Sec.||384.02k||N/A||1956|
|Ms. Sharon W. Klugewicz||Chief Operating Officer||262.54k||N/A||1968|
|Mr. Robert Scott Ludecker||Sr. VP of Global Sales & Marketing||380.57k||N/A||1967|
|Dr. Allan Richard Staley||Pres||N/A||N/A||N/A|
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Misonix, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 8. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 5; Compensation: 8.